CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +83,626 | 83,626 | ||
| 2021-11-02 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +7,964 | 7,964 | ||
| 2021-11-02 | Bensen Daniel Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +7,964 | 7,964 | ||
| 2021-11-02 | Harris Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +215,038 | 215,038 | ||
| 2021-11-02 | Harris Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +25,884 | 25,884 | ||
| 2021-11-02 | Harris Todd Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +25,884 | 25,884 | ||
| 2021-09-17 | Cormorant Asset Management, LP Former 10% Owner | Conversion | +757,432 | 757,432 | ||
| 2021-09-17 | Cormorant Asset Management, LP Former 10% Owner | Purchase | +312,500 | $16.00 | $5.0M | 1,069,932 |
| 2021-09-17 | Cormorant Asset Management, LP Former 10% Owner | Conversion · Series B Convertible Preferred Stock | −757,432 | 0 | ||
| 2021-09-17 | Kjellson Nina S Director | Conversion | +3,936,595 | 3,936,595 | ||
| 2021-09-17 | Kjellson Nina S Director | Conversion | +473,396 | 473,396 | ||
| 2021-09-17 | Kjellson Nina S Director | Conversion · Series A Preferred Stock | −1,333,334 | 0 | ||
| 2021-09-17 | Kjellson Nina S Director | Conversion · Series B Preferred Stock | −182,257 | 0 | ||
| 2021-09-17 | Kjellson Nina S Director | Conversion · Series B Preferred Stock | −182,258 | 0 | ||
| 2021-09-17 | Canaan XI L.P. 10% owner | Conversion | +3,936,595 | 3,936,595 | ||
| 2021-09-17 | Canaan XI L.P. 10% owner | Conversion | +473,396 | 473,396 | ||
| 2021-09-17 | Canaan XI L.P. 10% owner | Conversion · Series A Preferred Stock | −1,333,334 | 0 | ||
| 2021-09-17 | Canaan XI L.P. 10% owner | Conversion · Series B Preferred Stock | −182,257 | 0 | ||
| 2021-09-17 | Canaan XI L.P. 10% owner | Conversion · Series B Preferred Stock | −182,258 | 0 | ||
| 2021-09-17 | RA CAPITAL MANAGEMENT, L.P. Director | Conversion | +4,047,120 | 4,047,120 |
Page 19 of 21 · 417 trades